Activity of mushrooms against diabetic and inflammation: A review

Lena Ahmed Saleh Al-Faqeeh 1, *, Rafiuddin Naser 2, Kagne SR 3 and Subur W. Khan 4

1 Research Scholar in Microbiology, Department of Botany, Maulana Azad College of Arts, Science and Commerce, Dr. Rafiq Zakaria Campus, Rauza Bagh, Aurangabad, M.S., 431001, India.
2 Head Department of Botany, Maulana Azad College of Arts, Science and Commerce, Dr. Rafiq Zakaria Campus, Rauza Bagh, Aurangabad, M.S., 431001, India.
3 Associate Professor of Microbiology, Department of Microbiology, Badrinarayan Barwale Mahavidyalaya College, Jalna. M.S., 431001, India.
4 Department of Pharmacognosy, Y.B. Chavan College of Pharmacy, Dr. Rafiq Zakaria Campus, Aurangabad, M.S., 431001,  India.
 
Review Article
GSC Biological and Pharmaceutical Sciences, 2021, 14(02), 037-044.
Article DOI: 10.30574/gscbps.2021.14.2.0035
Publication history: 
Received on 23 January 2021; revised on 02 Februay 2021; accepted on 04 Februay 2021
 
Abstract: 
Since ancient people, mushroom have been used as a source of food and in therapeutic remedies. Many recent studies confirm different biological activities of mushrooms which include antioxidant, antimicrobial, anticancer, antidiabetic and anti-inflammatory activities.
Many mushroom species have been evaluated for their antidiabetic and anti-inflammatory activities. This study highlights the effectiveness of mushrooms as antidiabetic and anti-inflammatory agents. 
 
Keywords: 
Inflammation; Diabetic; Mushrooms; Active compounds; Anti-inflammation; Antidiabetic
 
Full text article in PDF: 
Share this